BRCA1 and ovarian carcinoma: Individuals at increased risk of breast and ovarian cancer associated with pathogenic variants in BRCA1/2 account for up to 10% of breast cancer cases, 15% of ovarian cancer cases, and up to 20% of cases of high-grade serous ovarian cancer, the most aggressive subtype [1,2,3,4].